CDNACareDx, Inc.
$63.68+336% 1Y
$63.68
$14.2852 weeks$69.81
The financials
CareDx, Inc. by the numbers
CareDx, Inc. (CDNA) reported revenue of $132M in Q2 2026 (quarter ended Jun 30, 2026), up 52% from the same quarter a year earlier. That came with net income of $111M (84% of revenue). For the full year FY2025, revenue was $380M (+14% year on year) and net income −$21M. Its largest product in Q2 2026 was Service at $100M, 84% of the disclosed total, well ahead of Patient And Digital Solutions at 16%. The next results filing is expected around Nov 3, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $132M | $87M | +52% |
| Operating income | $113M | −$11M | to a profit |
| Net income | $111M | −$8.6M | to a profit |
| Diluted EPS | $2.07 | −$0.16 | to a profit |
| Product | Revenue | Share |
|---|---|---|
| Service | $100M | 84% |
| Patient And Digital Solutions | $19M | 16% |
Business segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Jun 2026Total $119.2M (+11%)
Service grew +61% year on yearPatient And Digital Solutions +50% year on year
Segment Latestquarter on quarteryear on year
- Service$99.9M$99.9Mquarter on quarter +9.3%year on year +61%+9.3%+61%
- Patient And Digital Solutions$19.2M$19.2Mquarter on quarter +21%year on year +50%+21%+50%
On our screens:Most shorted stocks
Diagnostics & Research
Ranks #5 of 21 by RyuScore